In the clinical setting, high expressions of CSC markers CD90, CD133, and EpCAM in HCC tissues had been associated with cellular differentiation, poor prognosis, and metastasis [14,15,16,17,18]. This evidence concerns the gene THY1 and hepatocellular carcinoma.